Cargando…

Diabetes 2030: Insights from Yesterday, Today, and Future Trends

To forecast future trends in diabetes prevalence, morbidity, and costs in the United States, the Institute for Alternative Futures has updated its diabetes forecasting model and extended its projections to 2030 for the nation, all states, and several metropolitan areas. This paper describes the meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowley, William R., Bezold, Clement, Arikan, Yasemin, Byrne, Erin, Krohe, Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278808/
https://www.ncbi.nlm.nih.gov/pubmed/27124621
http://dx.doi.org/10.1089/pop.2015.0181
_version_ 1782502681232801792
author Rowley, William R.
Bezold, Clement
Arikan, Yasemin
Byrne, Erin
Krohe, Shannon
author_facet Rowley, William R.
Bezold, Clement
Arikan, Yasemin
Byrne, Erin
Krohe, Shannon
author_sort Rowley, William R.
collection PubMed
description To forecast future trends in diabetes prevalence, morbidity, and costs in the United States, the Institute for Alternative Futures has updated its diabetes forecasting model and extended its projections to 2030 for the nation, all states, and several metropolitan areas. This paper describes the methodology and data sources for these diabetes forecasts and discusses key implications. In short, diabetes will remain a major health crisis in America, in spite of medical advances and prevention efforts. The prevalence of diabetes (type 2 diabetes and type 1 diabetes) will increase by 54% to more than 54.9 million Americans between 2015 and 2030; annual deaths attributed to diabetes will climb by 38% to 385,800; and total annual medical and societal costs related to diabetes will increase 53% to more than $622 billion by 2030. Improvements in management reducing the annual incidence of morbidities and premature deaths related to diabetes over this time period will result in diabetes patients living longer, but requiring many years of comprehensive management of multiple chronic diseases, resulting in dramatically increased costs. Aggressive population health measures, including increased availability of diabetes prevention programs, could help millions of adults prevent or delay the progression to type 2 diabetes, thereby helping turn around these dire projections.
format Online
Article
Text
id pubmed-5278808
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-52788082017-02-04 Diabetes 2030: Insights from Yesterday, Today, and Future Trends Rowley, William R. Bezold, Clement Arikan, Yasemin Byrne, Erin Krohe, Shannon Popul Health Manag Original Articles To forecast future trends in diabetes prevalence, morbidity, and costs in the United States, the Institute for Alternative Futures has updated its diabetes forecasting model and extended its projections to 2030 for the nation, all states, and several metropolitan areas. This paper describes the methodology and data sources for these diabetes forecasts and discusses key implications. In short, diabetes will remain a major health crisis in America, in spite of medical advances and prevention efforts. The prevalence of diabetes (type 2 diabetes and type 1 diabetes) will increase by 54% to more than 54.9 million Americans between 2015 and 2030; annual deaths attributed to diabetes will climb by 38% to 385,800; and total annual medical and societal costs related to diabetes will increase 53% to more than $622 billion by 2030. Improvements in management reducing the annual incidence of morbidities and premature deaths related to diabetes over this time period will result in diabetes patients living longer, but requiring many years of comprehensive management of multiple chronic diseases, resulting in dramatically increased costs. Aggressive population health measures, including increased availability of diabetes prevention programs, could help millions of adults prevent or delay the progression to type 2 diabetes, thereby helping turn around these dire projections. Mary Ann Liebert, Inc. 2017-02-01 2017-02-01 /pmc/articles/PMC5278808/ /pubmed/27124621 http://dx.doi.org/10.1089/pop.2015.0181 Text en © Rowley et al, 2016; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Articles
Rowley, William R.
Bezold, Clement
Arikan, Yasemin
Byrne, Erin
Krohe, Shannon
Diabetes 2030: Insights from Yesterday, Today, and Future Trends
title Diabetes 2030: Insights from Yesterday, Today, and Future Trends
title_full Diabetes 2030: Insights from Yesterday, Today, and Future Trends
title_fullStr Diabetes 2030: Insights from Yesterday, Today, and Future Trends
title_full_unstemmed Diabetes 2030: Insights from Yesterday, Today, and Future Trends
title_short Diabetes 2030: Insights from Yesterday, Today, and Future Trends
title_sort diabetes 2030: insights from yesterday, today, and future trends
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278808/
https://www.ncbi.nlm.nih.gov/pubmed/27124621
http://dx.doi.org/10.1089/pop.2015.0181
work_keys_str_mv AT rowleywilliamr diabetes2030insightsfromyesterdaytodayandfuturetrends
AT bezoldclement diabetes2030insightsfromyesterdaytodayandfuturetrends
AT arikanyasemin diabetes2030insightsfromyesterdaytodayandfuturetrends
AT byrneerin diabetes2030insightsfromyesterdaytodayandfuturetrends
AT kroheshannon diabetes2030insightsfromyesterdaytodayandfuturetrends